Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Herbal injections for pain: are they safe? large study investigates

NCT ID NCT05318859

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study looked at the safety of pharmacopuncture—herbal extracts injected into acupuncture points—in 1,000 hospitalized adults with spine or joint problems. Researchers tracked infections and other side effects to see how often problems occur. The goal was to gather safety information, not to test whether the treatment works.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
pharmacopuncture (herbal extracts injected into acupuncture points)
What this could lead to
If results show pharmacopuncture is safe, it could support wider use of this treatment for musculoskeletal pain.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove effectiveness. Safety findings may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,000 people

The number who actually took part.

Started

Apr 2022

Finished

Feb 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Inpatients with diagnosed spinal joint disease who are admitted or scheduled to be admitted to Jaseng Hospital of Korean Medicine, Bucheon Jaseng Hospital of Korean Medicine, Daejeon Jaseng Hospital of Korean Medicine, or Haeundae Jaseng Hospital of Korean Medicine, Kyung Hee University Korean Medicine Hospital at Gangdong, Kyung Hee University Korean Medicine Hospital, Dongguk Traditional Herbal Medicine Clinic.

Ages

19 to 69 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Inpatients with diagnosed spinal joint disease * Patients who received pharmacopuncture treatment during hospitalization * Patients who are 19 years of age or older and less than 70 years old * Patients who agreed to participate in the clinical study and voluntarily given written informed consent Exclusion Criteria: * Patients with difficulty or refusal to give sign written informed consent * Patients for whom the researchers judge participation in the clinical study to be difficult

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Musculoskeletal diseases or conditions are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bucheon Jaseng Hospital of Korean Medicine

    Bucheon-si, Gyeonggi Province, 14598, South Korea

  • Daejeon Jaseng Hospital of Korean Medicine

    Daejeon, Daejeon, 35262, South Korea

  • Dongguk University Bundang Oriental Hospital

    Seoul, 13601, South Korea

  • Haeundae Jaseng Hospital of Korean Medicine

    Busan, South Korea

  • Jaseng Hospital of Korean Medicine

    Seoul, Gangnam-Gu, 135-896, South Korea

  • Kyung Hee University Hospital at Gangdong

    Seoul, 05278, South Korea

  • Kyung Hee University Korean Medicine Hospital

    Seoul, 02447, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.